CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and will present a company overview at 3:00 p.m. ET on September 8, 2025.

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world's largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock reduction SaaS platform, is proud to announce the addition of 28 deli, cheese and antipasti suppliers to the queue joining the ReposiTrak Traceability Network® (RTN). These companies will efficiently exchange intricate, FDA-required Key Data Elements (KDEs) for each Critical Tracking Event (CTE) in thei.

MENOMONEE FALLS, Wis.--(BUSINESS WIRE)--Kohl's Corporation (NYSE:KSS) today reported results for the second quarter ended August 2, 2025. Net sales decreased 5.1% and comparable sales decreased 4.2% Gross margin increased 28 basis points Diluted earnings per share (“EPS”) of $1.35 and adjusted diluted EPS of $0.56 (a) Raises full year 2025 financial outlook Michael Bender, Kohl's Interim Chief Executive Officer, said “Kohl's second quarter performance is a testament to the progress we are makin.

TORONTO--(BUSINESS WIRE)--Canada Goose Holdings Inc. (NYSE, TSX: GOOS) today announced that it will participate in the Goldman Sachs 32nd Annual Global Retailing Conference being held at the Conrad New York Downtown hotel in New York on September 3, 2025. We will host a fireside chat presentation at 3:15 pm ET and participate in one-on-one meetings. Beth Clymer, President, Chief Operating Officer and Neil Bowden, Chief Financial Officer will attend the conference. The fireside chat presentation.

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to participate and present at the following investor conferences in September: Cantor Global Healthcare Conference 2025: Fireside chat on Wednesday, September 3 at 3:55 pm ET H.C. Wainwright 27th Annual Global Investment Conference: Fireside chat on Monday, September 8.

WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:

STAMFORD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Alan Boehme has been appointed to the Board of Directors, effective August 27, 2025.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September:

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in fireside chats at the following upcoming investor events:

BROOKFIELD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2025 ended August 3, 2025.

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences:

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in Citi's 2025 Biopharma Back to School Summit, 2025 Wells Fargo Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn's Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

TORONTO--(BUSINESS WIRE)--Bench IQ, the AI-powered judicial intelligence platform used by the world's top law firms, today announced it has raised a $5.3 million seed round led by Battery Ventures and Inovia Capital, with participation from CIBC Innovation Banking, MVP Ventures, Maple VC and Haystack VC. The new funding will fuel Bench IQ's growth, with a focus on expanding its proprietary dataset, advancing its AI agents, and expanding the team in the U.S. and Canada. Leading AmLaw 200 law fir.

ANCHORAGE, Alaska , Aug. 27, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce that it is well underway with exploration at its 100% owned Whistler Gold-Copper Project (the "Whistler Project" or "Project") for the 2025 field season in Alaska. The program is focused on targeting continued growth through developing new drill targets at the Whistler Orbit and Muddy Creek prospect areas.

WATERLOO, ONTARIO / ACCESS Newswire / August 27, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) announced today that it has appointed software executive Barry Mainz to its Board of Directors. Mr. Mainz is a technology veteran with 30 years of experience in executive leadership, global sales, marketing, product-led growth, and product development.

BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--HERTHENA-Breast04 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic HR+/HER2- Breast Cancer.

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP).

RALEIGH, N.C.--(BUSINESS WIRE)--Driivz, a Vontier (NYSE: VNT) company and leading global software supplier to EV charging operators and service providers, today announced a partnership with ENAPI, a Berlin-based roaming connectivity platform, to deliver seamless, scalable EV charging across borders and networks, benefitting charge point operators (CPOs), e-mobility service providers (eMSPs), and EV drivers alike. This partnership unites the Driivz Smart EV Charging and Energy Management platfor.

ORRVILLE, Ohio , Aug. 27, 2025 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced results for the first quarter ended July 31, 2025, of its 2026 fiscal year.